• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,266.30 -123.15
(-0.30%)
Dow Jones
5,680.75 -4.19
(-0.07%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
85.39 0.69
(0.81%)
EUR-INR
96.28 0.21
(0.22%)
GBP-INR
113.48 0.52
(0.46%)
JPY-INR
0.59 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
98.3315118
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
132.89
418647.96
EPS(TTM)
Face Value()
Div & Yield %
13.13
1
0.77
 

PB Fintech spurts after broker upgrades rating
Mar 18,2025
The upgrade is based on strong growth expectations, improved valuations after a recent correction, and the belief that PB Fintech will outperform industry growth. The broker highlighted Policybazaar's dominant position in the insurance market and its effective sales strategies, while also dismissing concerns about competition and regulatory changes, citing PB Fintech's strong franchise and ability to secure favorable commissions.

PB Fintech is primarily engaged in providing online marketing, consulting and support services through its online portal policybazaar.com and paisabazaar.com largely for the financial service industry, including insurance. Its consolidated net profit rose 88.02% to Rs 71.54 crore while net sales rose 48.31% to Rs 1291.62 crore in Q3 December 2024 over Q3 December 2023.

PB Fintech's board on 11 March 2025, approved a Rs 696 crore investment in its newly formed healthcare subsidiary, PB Healthcare Services, for FY26, with shareholder approval pending. The investment, to be made via equity and compulsory convertible preference shares (CCPS), will fund operations, branding, and strategic initiatives. Alongside personal investments from key executives, the total investment reaches Rs 828.75 crore, potentially giving PB Fintech a 33.63% stake in the subsidiary.